About this FactMed analysis covering adverse side effect reports of ACAI patients who developed EXOSTOSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ACAI reported EXOSTOSIS to the FDA. A total of 25 ACAI drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACAI and EXOSTOSIS. In doing so, we compare ACAI with other drugs that cause EXOSTOSIS, to help you evaluate whether or not ACAI causes EXOSTOSIS. Likewise, this page shows the most highly-reported side effects of ACAI, so you can see if EXOSTOSIS ranks among ACAI's most well-known side effects.
Summary Statistics
Reports of ACAI causing EXOSTOSIS: 2
Reports of any side effect of ACAI : 25
Percentage of ACAI patients where EXOSTOSIS is a reported side effect: 8.0000%

FDA reports of any drug causing EXOSTOSIS : 5146
Average percentage for all medicated patients where EXOSTOSIS is reported as a complication: 0.0323%

Physician opinion on ACAI as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACAI:
VITAMIN SUPPLEMENTATION ( 6 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
MEDICAL DIET ( 1 patients )
ROUTINE HEALTH MAINTENANCE ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with EXOSTOSIS:

FOSAMAX (4752 patients)
ZOMETA (1257 patients)
AREDIA (778 patients)
VIOXX (774 patients)
ASPIRIN (715 patients)
AMBIEN (442 patients)
PREDNISONE (436 patients)
CELEBREX (434 patients)
FOSAMAX PLUS D (431 patients)
NEURONTIN (428 patients)
NEXIUM (419 patients)
LASIX (416 patients)
FORTEO (411 patients)
SYNTHROID (400 patients)
ALENDRONATE SODIUM (385 patients)
LIPITOR (380 patients)
LISINOPRIL (375 patients)
PRILOSEC (367 patients)
XANAX (361 patients)
PROTONIX (359 patients)
ACTONEL (349 patients)
LEVAQUIN (344 patients)
COUMADIN (331 patients)
BONIVA (326 patients)
PREMARIN (316 patients)
ENBREL (301 patients)
HYDROCHLOROTHIAZIDE (299 patients)
ATIVAN (297 patients)
DECADRON (294 patients)
AVONEX (286 patients)
ZOFRAN (286 patients)
OXYCONTIN (270 patients)
ZOCOR (261 patients)
ATENOLOL (260 patients)
ALBUTEROL (258 patients)
FOLIC ACID (256 patients)
ZOLOFT (254 patients)
PERCOCET (250 patients)
GABAPENTIN (241 patients)
VICODIN (237 patients)
SIMVASTATIN (235 patients)
PREVACID (232 patients)
COMPAZINE (231 patients)
METHOTREXATE (229 patients)
IBUPROFEN (222 patients)
MULTI-VITAMINS (221 patients)
DEXAMETHASONE (219 patients)
CALCIUM (UNSPECIFIED) (218 patients)
POTASSIUM CHLORIDE (216 patients)
[THERAPY UNSPECIFIED] (213 patients)
FEMARA (211 patients)
LORTAB (209 patients)
DILAUDID (205 patients)
NORVASC (204 patients)
TOPROL-XL (202 patients)
PAXIL (200 patients)
ARIMIDEX (198 patients)
ARANESP (196 patients)
ACETAMINOPHEN (194 patients)
FUROSEMIDE (194 patients)
LYRICA (191 patients)
CALCIUM (190 patients)
FLEXERIL (188 patients)
LEXAPRO (187 patients)
CHEMOTHERAPEUTICS NOS (184 patients)
ADVAIR DISKUS 100/50 (182 patients)
DURAGESIC-100 (181 patients)
ALPRAZOLAM (177 patients)
AVELOX (176 patients)
KEFLEX (174 patients)
VITAMIN D (174 patients)
CLINDAMYCIN (173 patients)
ZANTAC (173 patients)
TAXOTERE (172 patients)
HUMIRA (170 patients)
WARFARIN SODIUM (167 patients)
CIPROFLOXACIN (167 patients)
RADIATION THERAPY (166 patients)
REGLAN (165 patients)
OMEPRAZOLE (163 patients)
TAMOXIFEN CITRATE (162 patients)
AMOXICILLIN (161 patients)
FLAGYL (160 patients)
THALIDOMIDE (160 patients)
ZITHROMAX (159 patients)
CELEXA (158 patients)
PROZAC (157 patients)
HERCEPTIN (157 patients)
CYMBALTA (157 patients)
AUGMENTIN '125' (156 patients)
ALLEGRA (156 patients)
MOBIC (155 patients)
COLACE (153 patients)
MORPHINE (152 patients)
CYTOXAN (150 patients)
OXYCODONE HCL (150 patients)
TAXOL (149 patients)
FASLODEX (149 patients)
LORAZEPAM (147 patients)
PLAVIX (145 patients)
FENTANYL (145 patients)
VITAMINS (UNSPECIFIED) (142 patients)
PERIDEX (140 patients)
VITAMIN E (140 patients)
ACTOS (138 patients)
SINGULAIR (137 patients)
VELCADE (137 patients)
DIFLUCAN (135 patients)
COREG (134 patients)
ACYCLOVIR (133 patients)
CEPHALEXIN (133 patients)
MS CONTIN (131 patients)
REVLIMID (130 patients)
WELLBUTRIN (126 patients)
PREDNISONE TAB (125 patients)
NYSTATIN (123 patients)
LEVOTHYROXINE SODIUM (123 patients)
RESTORIL (122 patients)
VITAMIN D (UNSPECIFIED) (122 patients)
NAPROXEN (122 patients)
ALLOPURINOL (122 patients)
CRESTOR (120 patients)
METRONIDAZOLE (119 patients)
LANTUS (118 patients)
TYSABRI (118 patients)
HYDROCODONE (117 patients)
LOVENOX (117 patients)
BEXTRA (117 patients)
CARBOPLATIN (116 patients)
MORPHINE SULFATE (115 patients)
KLOR-CON (114 patients)
ASCORBIC ACID (113 patients)
GLIPIZIDE (111 patients)
NAVELBINE (111 patients)
SEROQUEL (110 patients)
PROCRIT /00909301/ (110 patients)
FLONASE (109 patients)
TEMAZEPAM (108 patients)
EFFEXOR (108 patients)
CHLORHEXIDINE GLUCONATE (108 patients)
PEPCID (107 patients)
DARVOCET-N 100 (106 patients)
CALCIUM CARBONATE (105 patients)
XELODA (104 patients)
CHANTIX (104 patients)
MIRALAX (104 patients)
CLARITIN (104 patients)
FLUCONAZOLE (104 patients)
VALIUM (104 patients)
ELAVIL (103 patients)
ADRIAMYCIN PFS (103 patients)
EPOGEN (102 patients)
ALTACE (102 patients)
HYDROCODONE BITARTRATE (101 patients)
RANITIDINE (101 patients)
NEUPOGEN (100 patients)
ZYRTEC (100 patients)
DIOVAN (100 patients)
INSULIN (99 patients)
PREMPRO (98 patients)
PLAQUENIL (98 patients)
COZAAR (97 patients)
LIDODERM (95 patients)
TYLENOL (95 patients)
CITALOPRAM HYDROBROMIDE (93 patients)
IRON (93 patients)
TYLENOL-500 (92 patients)
HUMALOG (91 patients)
CIPRO (90 patients)
METFORMIN HCL (89 patients)
AZITHROMYCIN (89 patients)
DOXYCYCLINE (89 patients)
PRAVACHOL (89 patients)
VERSED (89 patients)
VITAMIN B-12 (88 patients)
LOTREL (88 patients)
METHYLPREDNISOLONE (87 patients)
DEMEROL (87 patients)
OXYCODONE (86 patients)
DARVOCET-N 50 (86 patients)
VANCOMYCIN (86 patients)
AVANDIA (86 patients)
AROMASIN (86 patients)
EVISTA (86 patients)
LACTULOSE (85 patients)
NEULASTA (84 patients)
MULTI-VITAMIN (84 patients)
MELOXICAM (83 patients)
DIGOXIN (81 patients)
CORTICOSTEROIDS (UNSPECIFIED) (80 patients)
MULTIVITAMIN ^LAPPE^ (80 patients)
MEGACE (79 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (79 patients)
ROCEPHIN (79 patients)
PENICILLIN ^GRUNENTHAL^ (79 patients)
PROCHLORPERAZINE (79 patients)
KLONOPIN (79 patients)
ULTRAM (78 patients)
PENICILLIN VK (78 patients)
PHENERGAN (78 patients)
PROMETHAZINE (78 patients)
BENADRYL (76 patients)
METOCLOPRAMIDE (76 patients)
LOMOTIL (75 patients)
STEROIDS NOS (74 patients)
DOCUSATE (74 patients)
AMLODIPINE (74 patients)
GLUCOPHAGE (73 patients)
ZESTRIL (73 patients)
REBIF (72 patients)
Most common side effects for patients taking ACAI:
RENAL FAILURE ACUTE (6 patients)
ATRIOVENTRICULAR BLOCK SECOND DEGREE (5 patients)
FALL (5 patients)
NEUROPATHY PERIPHERAL (4 patients)
MEMORY IMPAIRMENT (3 patients)
WEIGHT DECREASED (3 patients)
MUSCLE TWITCHING (3 patients)
FATIGUE (3 patients)
VISUAL ACUITY REDUCED (3 patients)
BALANCE DISORDER (3 patients)
STRESS (3 patients)
EXCORIATION (3 patients)
ERYTHEMA (3 patients)
COGNITIVE DISORDER (3 patients)
COORDINATION ABNORMAL (3 patients)
PAIN (3 patients)
DEHYDRATION (3 patients)
DERMATITIS INFECTED (2 patients)
PRODUCT ADHESION ISSUE (2 patients)
PAIN IN EXTREMITY (2 patients)
RASH (2 patients)
ONYCHOCLASIS (2 patients)
DRY SKIN (2 patients)
ONYCHALGIA (2 patients)
CARPAL TUNNEL SYNDROME (2 patients)
ROTATOR CUFF REPAIR (2 patients)
ROTATOR CUFF SYNDROME (2 patients)
EXOSTOSIS (2 patients)
TRANSITIONAL CELL CARCINOMA (2 patients)
VISUAL IMPAIRMENT (2 patients)
NAUSEA (2 patients)
GASTROENTERITIS VIRAL (2 patients)
NASOPHARYNGITIS (2 patients)
HOT FLUSH (2 patients)
VOMITING (2 patients)
LIMB CRUSHING INJURY (2 patients)
INCISION SITE HAEMORRHAGE (2 patients)
LOWER EXTREMITY MASS (2 patients)
INSOMNIA (1 patients)
KIDNEY INFECTION (1 patients)
ABDOMINAL PAIN (1 patients)
INFLUENZA LIKE ILLNESS (1 patients)
HYPONATRAEMIA (1 patients)
MONOPLEGIA (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE SCLEROSIS RELAPSE (1 patients)
HYPERTENSION (1 patients)
MYALGIA (1 patients)
HERPES ZOSTER (1 patients)
FEELING HOT (1 patients)
EAR INFECTION (1 patients)
NEUTROPENIA (1 patients)
NON-HODGKIN'S LYMPHOMA (1 patients)
DYSPEPSIA (1 patients)
DRUG INEFFECTIVE (1 patients)
OROPHARYNGEAL PAIN (1 patients)
DIZZINESS (1 patients)
DIVERTICULITIS (1 patients)
PHARYNGITIS (1 patients)
DIARRHOEA (1 patients)
PYREXIA (1 patients)
CYSTITIS (1 patients)
RENAL CYST (1 patients)
BLOOD TRIGLYCERIDES INCREASED (1 patients)
RHEUMATOID ARTHRITIS (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLADDER DISORDER (1 patients)
SHOCK (1 patients)
SKIN LACERATION (1 patients)
STAPHYLOCOCCAL INFECTION (1 patients)
BLADDER CANCER (1 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (1 patients)
BASAL CELL CARCINOMA (1 patients)
URTICARIA (1 patients)
UVEITIS (1 patients)
ASTHENIA (1 patients)
ARTHRALGIA (1 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (1 patients)
ACUTE HEPATIC FAILURE (1 patients)
WOUND INFECTION (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACAI


Issue Description / Topic Timestamp
QUESTION
BURNING SENSATION
I have not taken acai berry but have experienced a burning sensation and a tingling "pins and needles" sensation from taking maqui berry capsules. There is very little research on humans on maqui berry's side effects. I am wondering if anyone else has experienced similar. M 2017-05-09 17:39:37

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about EXOSTOSIS and ACAI, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACAI, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACAI. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACAI experts. If you are a healthcare provider experienced in prescribing ACAI, please register here.

Your online appointment book for Tulsa Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use